Key result
Cardiac transplantation restores function in end-stage disease despite ~59% mortality from rejection and sepsis.
Why the study?
Human cardiac transplantation was evaluated as potential palliation for patients with end-stage cardiac disease who had no other available treatments.
Does cardiac transplantation provide palliation and effective cardiac function in patients with end-stage cardiac disease?
Case Report (n=17)
Does cardiac transplantation provide palliation and effective cardiac function in patients with end-stage cardiac disease?
Early experience with human cardiac transplantation demonstrates it can provide effective cardiac function for end-stage heart disease, though it is limited by high mortality from rejection and infection.
Answers are grounded in this paper and cite their sources.
Early transplant experience shows functional recovery despite high rejection mortality; leaves open optimization of immunosuppression before wider adoption.
Transplantation of the human heart may provide palliation for patients with end-stage cardiac disease for whom no other treatment is available. Cardiac transplantation was performed in 17 patients undergoing 18 heart transplants. Five early deaths occurred: three from acute cardiac rejection after one week and one each from pre-existing diseases and complications of immunosuppressive therapy. The transplanted heart provided effective cardiac function for each surviving patient. Two late deaths occurred from sepsis. Three patients died between five and nearly seven months after operation from chronic cardiac rejection. Clinical investigations of the role of histocompatibility testing, methods of immunosuppressive therapy, recognition and management of rejection, search for preformed anti-heart antibodies, physiological evaluation of the denervated transplanted heart, and causes of histological changes in the transplanted hearts are continuing. Further clinical trial is needed to determine the role of cardiac transplantation in palliating advanced myocardial insufficiency.
No takes yet. Share an insight, caveat, or question.
Cooley et al. (1969) conducted a case report in End-stage cardiac disease (n=17). Cardiac transplantation was evaluated. Cardiac transplantation in 17 patients with end-stage cardiac disease provided effective cardiac function for survivors, though 10 deaths occurred from rejection, sepsis, and other causes.
Synapse has enriched 10 related papers. Consider them for comparative context: